Concepedia

Bo Peng

BP

51

Publications

3.1K

Citations

26

H-Index

2010

Active since

Affiliations

National University of Singapore(Current)

Harbin Medical University

Chinese Academy of Sciences

Second Affiliated Hospital of Harbin Medical University

AstraZeneca (United States)

Bo Peng is an author at National University of Singapore specializing in medicine, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

2010–2025

51

Publications

51

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

Adriana E. Tron, Matthew A. Belmonte, Ammar Adam et al. · Nature Communications · 2018 · 479 citations · Full text

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer

Jianming Xu, Haiping Jiang, Yueyin Pan et al. · JAMA · 2023 · 300 citations · Full text

Systemic immune-inflammation index and bone mineral density in postmenopausal women: A cross-sectional study of the national health and nutrition examination survey (NHANES) 2007-2018

Yuchen Tang, Bo Peng, Jinmin Liu et al. · Frontiers in Immunology · 2022 · 175 citations · Full text

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit

Jie Wang, Keke Fei, Jing Hua et al. · mAbs · 2019 · 148 citations · Full text

, , +24

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan et al. · Nature Communications · 2022 · 147 citations · Full text

Rows per page

1–5 of 51